Showing 5421 - 5430 of 5468 for "United States (National)" with applied filters
01 September 2018 by Managing Intellectual Property
Resolution Chemicals v AstraZeneca B.V. and Shionogi (Supreme Court of The Netherlands, The Hague, June 8 2018) deals with the extent of the protection that is conferred by patent EP0521471 (EP 471), for rosuvastatin, a new cholesterol inhibitor.
01 September 2018 by Thomas Gibb
In recent years, machine learning and so-called ‘artificial intelligence’ systems have once again come into the spotlight.
31 August 2018 by Özge Atilgan Karakulak
Özge Atılgan Karakulak and Güldeniz Doğan Alkan of Gün + Partners examine the advantages and disadvantages of TÜRKSMD, a new company set up by the Turkish IP Office to value intellectual property rights
31 August 2018 by Managing Intellectual Property
The decision of the Full Federal Court in GlaxoSmithKline (GSK) Consumer Healthcare Investments (Ireland) (No 2) Limited v Generic Partners Pty Limited (2018) FCAFC 71 (May 10 2018) indicates that a mistake in a claim cannot be ignored even where the skilled person understands that a mistake has been made.
04 July 2018 by Managing Intellectual Property
Meet with start-up founders, entrepreneurs, investors, corporate and brand executives, and thought leaders at unbound London festival
02 July 2018 by Karen Artz Ash
Although it is the general policy of the USPTO’s Trademark Trial and Appeal Board (TTAB) to suspend opposition proceedings when the parties to such proceedings become involved in a civil action which may be dispositive of the case, a recent decision issued by the US District Court for the District of Delaware in Tigercat Int’l, Inc. v Caterpillar Inc. indicates that there are circumstances where, conversely, federal courts will stay a litigation pending a TTAB ruling.
02 July 2018 by Managing Intellectual Property
On June 1 2018, the Supreme People’s Court of China (SPC) issued Provisions on Several Issues in Adjudicating Patent Granting and Affirming Administrative Cases I (the Draft Provisions). The general public can submit its opinions and comments by July 1 2018.
02 July 2018 by Managing Intellectual Property
CRISPR technology enables genes to be edited and can eventually treat diseases caused by gene mutations.
02 July 2018 by Managing Intellectual Property
The general limitation period for juridical actions in Austria is 30 years. However, particular laws can stipulate shorter or longer limitation periods.
02 July 2018 by Managing Intellectual Property
Turkey has welcomed the new Intellectual Property Code (the IP Code) numbered 6769. This came into force on January 10 2017.